Finasteride/Latanoprost/Minoxidil

N/A

Report date: 2026/05/18 11:52:08

Base Information

Drug NameFinasteride/Latanoprost/Minoxidil
Drug Alias NameTherapy-07TH-07
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase inhibitorsProstanoid FP receptor agonistsVoltage-gated potassium channel agonists
TargetsSteroid 5 alpha reductaseProstanoid FP receptorVoltage-gated potassium channel
Therapy Area/IndicationsAlopecia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaIndia
CombinationsYes FinasterideLatanoprostMinoxidil
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTriple Hair Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesTriple Hair IncTriple Hair Group IncAkums Drugs & Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsAlopecia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A